Zanolimumab (HuMax-CD4®), a fully human monoclonal antibody in clinical development for cutaneous T-cell lymphoma. Hematol Meeting Rep [Internet]. 2009 Jun. 23 [cited 2025 Aug. 7];2(5). Available from: https://journals.pagepress.org/hmr/article/view/736